Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071936 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Pain Syndrome
Pain, Chronic
Chronic Pain
Chronic Pain Syndrome
Neuropathic Pain
Peripheral Neuropathy
Peripheral Neuralgia
Peripheral Nerve Injury
Post Operative Pain
Post-Traumatic Neuralgia
Plexopathy

Interventions

DRUG: Adezunap (AP707)
DRUG: Placebo

Sponsor

Apurano Pharmaceuticals GmbH